Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Sohag University, Sohag, Egypt.
Department of Dermatology, Venereology and Andrology, Sohag General Hospital, Sohag, Egypt.
J Cosmet Dermatol. 2023 Dec;22(12):3379-3386. doi: 10.1111/jocd.15834. Epub 2023 Jun 14.
Melasma is a distressing disfiguring acquired pigmentary disorder especially affecting females and it is of high tendency of recurrence. Up till now, treatment of melasma is a challenging problem.
We evaluated the effectiveness of microneedling with glutathione versus microneedling alone in treatment of melasma.
In this study, 29 adult females with epidermal type of melasma (confirmed with Wood's light examination) were enrolled. The affected area was subjected to microneedling using dermapen followed by application of glutathione solution on the right side only. This session was performed every 2 weeks for 3 months (six sessions for every patient). The response to therapy was measured using modified melasma area and severity index (m MASI) that were calculated on each side of the face (Hemi- m MASI) before treatment sessions.
There was statistically significant reduction in the mean of Hemi- m MASI score over the sessions on both sides of the face but the right side (microneedling with glutathione) showed more reduction and earlier response to therapy than the left side (microneedling alone). On the left side, mean of Hemi- m MASI score before and after sessions was (4.06 ± 1.91, 2.31 ± 1.450) and on the right side, it was (4.21 ± 2.08, 1.96 ± 1.30), respectively and this was statistically significant. Percentage of improvement on the left side was 46.92 ± 16.30 (%) while on the right side was 55.17 ± 15.50 (%) and this was statistically significant.
Microneedling is an effective promising tool in treatment of melasma and its combination with glutathione as a whitening agent, increases and accelerates its efficacy. So, combined therapy is more preferred than monotherapy in treatment of facial melasma.
黄褐斑是一种令人苦恼的获得性色素沉着障碍,尤其影响女性,且易于复发。到目前为止,黄褐斑的治疗仍是一个具有挑战性的问题。
我们评估了微针联合谷胱甘肽与单纯微针对黄褐斑的疗效。
本研究纳入了 29 例表皮型黄褐斑成年女性(经伍德灯检查确诊)。在右侧,用 Dermapen 进行微针治疗,然后仅在右侧涂抹谷胱甘肽溶液。每 2 周进行一次治疗,共进行 3 个月(每位患者共 6 次)。在治疗前和治疗过程中,使用改良黄褐斑面积和严重程度指数(m MASI)评估面部两侧(半面部 m MASI)的治疗反应。
在治疗过程中,面部两侧的平均 Hemi- m MASI 评分均有统计学意义的降低,但右侧(微针联合谷胱甘肽)的降低更为明显,且对治疗的反应更早。左侧治疗前后的 Hemi- m MASI 评分均值分别为(4.06±1.91,2.31±1.45),右侧分别为(4.21±2.08,1.96±1.30),差异有统计学意义。左侧的改善百分比为 46.92%±16.30%,右侧为 55.17%±15.50%,差异有统计学意义。
微针是治疗黄褐斑的一种有效且有前景的工具,联合谷胱甘肽作为美白剂可增加并加速其疗效。因此,在治疗面部黄褐斑时,联合治疗比单独治疗更受欢迎。